What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Endocrinology
- Disease
Myles Wolf mostly deals with Internal medicine, Endocrinology, Kidney disease, Fibroblast growth factor 23 and Vitamin D and neurology.
His study focuses on the intersection of Internal medicine and fields such as Gastroenterology with connections in the field of Quartile.
His Endocrinology research includes themes of Nephrology, Parathyroid hormone, Pathogenesis and Preeclampsia.
The various areas that Myles Wolf examines in his Kidney disease study include Etelcalcetide, Dialysis, End stage renal disease and Renal function.
His work carried out in the field of Fibroblast growth factor 23 brings together such families of science as Calcitriol, Phosphorus metabolism, Inflammation, Phosphate and Thoracic aorta.
His work deals with themes such as Genetics, National Health and Nutrition Examination Survey, Physiology and Disease, which intersect with Vitamin D and neurology.
His most cited work include:
- Vitamin D Deficiency and Risk of Cardiovascular Disease (1889 citations)
- Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. (1331 citations)
- Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. (1331 citations)
What are the main themes of his work throughout his whole career to date?
Internal medicine, Endocrinology, Kidney disease, Fibroblast growth factor 23 and Renal function are his primary areas of study.
Myles Wolf interconnects Gastroenterology and Cardiology in the investigation of issues within Internal medicine.
Myles Wolf usually deals with Gastroenterology and limits it to topics linked to Hazard ratio and Proportional hazards model.
Myles Wolf works mostly in the field of Endocrinology, limiting it down to topics relating to Secondary hyperparathyroidism and, in certain cases, Hyperparathyroidism.
As a member of one scientific family, Myles Wolf mostly works in the field of Kidney disease, focusing on Cohort and, on occasion, Heart failure.
In his work, Urinary system is strongly intertwined with Excretion, which is a subfield of Fibroblast growth factor 23.
He most often published in these fields:
- Internal medicine (78.72%)
- Endocrinology (47.72%)
- Kidney disease (47.72%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (78.72%)
- Kidney disease (47.72%)
- Fibroblast growth factor 23 (33.43%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Internal medicine, Kidney disease, Fibroblast growth factor 23, Renal function and Gastroenterology.
His Internal medicine study combines topics in areas such as Endocrinology and Cardiology.
Myles Wolf studied Endocrinology and Calcium that intersect with Calciphylaxis.
His research integrates issues of Biomarker, Cohort study, Cohort and Receiver operating characteristic in his study of Kidney disease.
His Fibroblast growth factor 23 study integrates concerns from other disciplines, such as Interquartile range, Secondary hyperparathyroidism, Anemia and Bone remodeling.
His Gastroenterology study combines topics from a wide range of disciplines, such as Adverse effect, Phosphate, Randomized controlled trial and Iron-deficiency anemia.
Between 2018 and 2021, his most popular works were:
- FGF23 at the crossroads of phosphate, iron economy and erythropoiesis. (50 citations)
- Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials (45 citations)
- Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial. (44 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Diabetes mellitus
His primary scientific interests are in Internal medicine, Kidney disease, Fibroblast growth factor 23, Renal function and Gastroenterology.
His Internal medicine research incorporates elements of Diabetes mellitus and Cardiology.
Myles Wolf interconnects Disease, Cohort and Bioinformatics in the investigation of issues within Kidney disease.
His Fibroblast growth factor 23 research includes themes of Phosphate binder, Anemia and Hemodialysis.
His work carried out in the field of Gastroenterology brings together such families of science as Iron-deficiency anemia, Tolerability, Adverse effect, Bicarbonate and Phosphate.
Hyperphosphatemia is a primary field of his research addressed under Endocrinology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
